181 related articles for article (PubMed ID: 23731388)
1. A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus.
Ferbas J; Belouski SS; Horner M; Kaliyaperumal A; Chen L; Boyce M; Colaço CB; McHugh N; Quick V; Nicholl RJ; Siu G; Chung J
Br J Clin Pharmacol; 2013 Aug; 76(2):188-202. PubMed ID: 23731388
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of canine T-cell dependent antibody response to the primary and secondary immunization with keyhole limpet hemocyanin.
Kawai R; Aida T; Hattori H; Furukawa T; Mori K; Takasaki W; Takahashi N; Kawada T
J Toxicol Sci; 2013; 38(4):571-9. PubMed ID: 23824013
[TBL] [Abstract][Full Text] [Related]
3. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells.
Thornton BP; Vetvicka V; Ross GD
Clin Exp Immunol; 1996 Jun; 104(3):531-7. PubMed ID: 9099940
[TBL] [Abstract][Full Text] [Related]
4. Improvement and optimization of a T-cell-dependent antibody response (TDAR) method for BALB/c mice using keyhole limpet hemocyanin (KLH) as specific antigen.
Chang P; Huang L; Huang M; Tian S; Yang Z
J Immunotoxicol; 2019 Dec; 16(1):149-154. PubMed ID: 31290717
[TBL] [Abstract][Full Text] [Related]
5. Effect of active immunization with IL-17A on B cell function and infection risk in pristane-induced lupus model.
Handono K; Pratama MZ; Sari DK; Hermawan HO; Agdana HM; Kawuningan KB; Nur'aini N; Hasanah D; Kalim H
Int J Rheum Dis; 2018 Jun; 21(6):1277-1286. PubMed ID: 29879320
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial with a delayed-type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man.
Saghari M; Gal P; Ziagkos D; Burggraaf J; Powell JF; Brennan N; Rissmann R; van Doorn MBA; Moerland M
Br J Clin Pharmacol; 2021 Apr; 87(4):1953-1962. PubMed ID: 33025648
[TBL] [Abstract][Full Text] [Related]
7. Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters.
Aarntzen EH; de Vries IJ; Göertz JH; Beldhuis-Valkis M; Brouwers HM; van de Rakt MW; van der Molen RG; Punt CJ; Adema GJ; Tacken PJ; Joosten I; Jacobs JF
Cancer Immunol Immunother; 2012 Nov; 61(11):2003-11. PubMed ID: 22527252
[TBL] [Abstract][Full Text] [Related]
8. Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.
Menge AC; Michalek SM; Russell MW; Mestecky J
Infect Immun; 1993 May; 61(5):2162-71. PubMed ID: 8478106
[TBL] [Abstract][Full Text] [Related]
9. Analysis of serum binding to DNA and other ligands in systemic lupus erythematosus.
Barnes RM; Kenton P
Immunol Lett; 1985; 10(2):99-102. PubMed ID: 3897037
[TBL] [Abstract][Full Text] [Related]
10. Measurement of primary in vivo IgM- and IgG-antibody response to KLH in humans: implications of pre-immune IgM binding in antigen-specific ELISA.
Korver K; Zeijlemaker WP; Schellekens PT; Vossen JM
J Immunol Methods; 1984 Nov; 74(2):241-51. PubMed ID: 6501888
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response to keyhole limpet haemocyanin, the protein carrier in cancer vaccines.
Kantele A; Häkkinen MP; Zivny J; Elson CO; Mestecky J; Kantele JM
Clin Dev Immunol; 2011; 2011():614383. PubMed ID: 21716728
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity of IgG anti-DNA-secreting B cells in patients with systemic lupus erythematosus.
Klinman DM; Shirai A; Conover J; Steinberg AD
Eur J Immunol; 1994 Jan; 24(1):53-8. PubMed ID: 8020571
[TBL] [Abstract][Full Text] [Related]
13. Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus.
Sullivan BA; Tsuji W; Kivitz A; Peng J; Arnold GE; Boedigheimer MJ; Chiu K; Green CL; Kaliyaperumal A; Wang C; Ferbas J; Chung JB
Lupus Sci Med; 2016; 3(1):e000146. PubMed ID: 27099766
[TBL] [Abstract][Full Text] [Related]
14. Abnormal immunoglobulin G subclass production in response to keyhole limpet haemocyanin in atopic patients.
Falconer AE; Friedmann PS; Bird P; Calvert JE
Clin Exp Immunol; 1992 Sep; 89(3):495-9. PubMed ID: 1516265
[TBL] [Abstract][Full Text] [Related]
15. Endogenous glucocorticoids play a positive regulatory role in the anti-keyhole limpet hemocyanin in vivo antibody response.
Fleshner M; Deak T; Nguyen KT; Watkins LR; Maier SF
J Immunol; 2001 Mar; 166(6):3813-9. PubMed ID: 11238624
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients.
Wimmers F; de Haas N; Scholzen A; Schreibelt G; Simonetti E; Eleveld MJ; Brouwers HM; Beldhuis-Valkis M; Joosten I; de Jonge MI; Gerritsen WR; de Vries IJ; Diavatopoulos DA; Jacobs JF
Sci Rep; 2017 Mar; 7():43486. PubMed ID: 28344338
[TBL] [Abstract][Full Text] [Related]
17. Sudden appearance of anti-protein IgG1-forming cell precursors early during primary immunization.
Nossal GJ; Riedel C
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4679-83. PubMed ID: 2786635
[TBL] [Abstract][Full Text] [Related]
18. The Possible Effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus.
Tu J; Wang X; Geng G; Xue X; Lin X; Zhu X; Sun L
Front Immunol; 2018; 9():187. PubMed ID: 29497417
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous Presence of Non- and Highly Mutated Keyhole Limpet Hemocyanin (KLH)-Specific Plasmablasts Early after Primary KLH Immunization Suggests Cross-Reactive Memory B Cell Activation.
Giesecke C; Meyer T; Durek P; Maul J; Preiß J; Jacobs JFM; Thiel A; Radbruch A; Ullrich R; Dörner T
J Immunol; 2018 Jun; 200(12):3981-3992. PubMed ID: 29735481
[TBL] [Abstract][Full Text] [Related]
20. In vitro nucleoside specific immune response by lymphocytes from systemic lupus erythematosus.
Morimoto C; Steinberg AD; Schlossman SF; Borel Y
J Clin Invest; 1983 May; 71(5):1402-9. PubMed ID: 6189861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
